SEC Filings for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.29675   0.0163 (+5.81%) Volume: 309.91k 3:59 PM EST Nov 23, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
424B2Prospectus [Rule 424(b)(2)]3006/01/2018
424B2Prospectus [Rule 424(b)(2)]2805/31/2018
8-KCurrent report pursuant to Section 13 or 15(d)2805/02/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)4704/05/2018
8-KCurrent report pursuant to Section 13 or 15(d)302/14/2018
8-KCurrent report pursuant to Section 13 or 15(d)401/30/2018
10-QGeneral form for quarterly reports under Section 13 or 15(d)5101/16/2018
8-KCurrent report pursuant to Section 13 or 15(d)712/19/2017
10-KAnnual report pursuant to Section 13 or 15(d)7412/08/2017
NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405211/29/2017
8-KCurrent report pursuant to Section 13 or 15(d)311/13/2017
8-KCurrent report pursuant to Section 13 or 15(d)311/13/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)4307/17/2017
424B5Prospectus [Rule 424(b)(5)]2905/10/2017
8-KCurrent report pursuant to Section 13 or 15(d)3405/10/2017
123456789101112131415